Pharma Reaserch Prod Co Ltd (214450) — Net Asset Quality Index
Pharma Reaserch Prod Co Ltd (214450) has a Net Asset Quality Index of 69.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩1.04 Trillion minus total liabilities of ₩320.01 Billion yields net assets of ₩723.88 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Pharma Reaserch Prod Co Ltd (214450) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pharma Reaserch Prod Co Ltd Net Asset Quality Index Over Time (2015–2025)
This chart shows how Pharma Reaserch Prod Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the index stands at 69.3%, representing net assets of ₩723.88 Billion against total assets of ₩1.04 Trillion KRW. See 214450 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Pharma Reaserch Prod Co Ltd (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for Pharma Reaserch Prod Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Pharma Reaserch Prod Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 69.3% | ₩723.88 Billion | ₩1.04 Trillion | ₩320.01 Billion | ▲ +2.8 pp |
| 2024 | 66.5% | ₩569.44 Billion | ₩855.70 Billion | ₩286.26 Billion | ▼ -19.8 pp |
| 2023 | 86.3% | ₩462.19 Billion | ₩535.28 Billion | ₩73.09 Billion | ▲ +14.5 pp |
| 2022 | 71.9% | ₩343.50 Billion | ₩478.06 Billion | ₩134.55 Billion | ▲ +0.4 pp |
| 2021 | 71.4% | ₩305.44 Billion | ₩427.65 Billion | ₩122.20 Billion | ▼ -5.3 pp |
| 2020 | 76.7% | ₩245.42 Billion | ₩319.83 Billion | ₩74.41 Billion | ▼ -0.7 pp |
| 2019 | 77.5% | ₩209.07 Billion | ₩269.93 Billion | ₩60.85 Billion | ▲ +0.9 pp |
| 2018 | 76.5% | ₩197.62 Billion | ₩258.19 Billion | ₩60.56 Billion | ▼ -18.1 pp |
| 2017 | 94.6% | ₩178.85 Billion | ₩189.03 Billion | ₩10.18 Billion | ▼ -1.1 pp |
| 2016 | 95.7% | ₩171.64 Billion | ₩179.33 Billion | ₩7.69 Billion | ▲ +3.1 pp |
| 2015 | 92.6% | ₩156.75 Billion | ₩169.31 Billion | ₩12.56 Billion | — |